Apixaban superior to warfarin across range of INR values, ARISTOTLE analysis

The reduction in the primary efficacy end point of stroke or systemic embolism with apixaban was observed across a broad range of INR control in the warfarin-treated patients.
Source: theHeart.org - Category: Cardiology Source Type: news